The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted agents and treatment combinations, as well as evolving molecular-based ...

Erisyon, a leading provider of single-molecule proteomics technology, today announced that it has been awarded a $2.2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) ...

An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...

Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened ...

The proportion of female speakers increased over time, but they remain underrepresented in procedural and other specialties.

In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...

Dr. Kossler received her MD from the Georgetown School of Medicine and completed her ophthalmology residency and oculofacial plastic and orbital surgery fellowship at the Bascom Palmer Eye Institute.

National Institute for Research in Digital Health and Data Science (NIRDHDS) will host a two-day workshop on “Unlocking AI for Healthcare: A Beginner’s Guide to Medical Imaging for Early Diagnosis.” ...

Acupuncture research is vitally important for the advancement of traditional East Asian medicine (TEAM). From basic science ...

After nabbing an FDA approval last summer for its T-cell lymphoma treatment Lymphir, Citius Oncology is eyeing strategic ...

In recent years, the FDA has amped up its supervision of accelerated approvals, including by requiring that confirmatory ...